HCPCS Level II J3357: Ustekinumab, Subcutaneous Injection, 1 mg
HCPCS Level II code J3357 represents ustekinumab, for subcutaneous injection, 1 mg, used to report administration of the biologic medication in outpatient or clinic settings for conditions treated with subcutaneous ustekinumab; the service type is drug administration (subcutaneous biologic) and the typical site of service is outpatient clinic or physician office.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J3357 policy alerts
Get alerted when payer policies referencing J3357 are released or updated.
Monitor payer policy activity